Shinichi Koizumi
Directeur/Membre du Conseil chez TSUBOTA LABORATORY INCORPORATED
Postes actifs de Shinichi Koizumi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TSUBOTA LABORATORY INCORPORATED | Directeur/Membre du Conseil | 01/06/2020 | - |
| Independent Dir/Board Member | 01/06/2020 | - | |
AskAt, Inc.
 AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Directeur/Membre du Conseil | 01/01/2013 | - |
| Directeur Technique/Scientifique/R&D | 01/01/2013 | - | |
| Corporate Officer/Principal | 01/01/2013 | - |
Historique de carrière de Shinichi Koizumi
Anciens postes connus de Shinichi Koizumi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| RAQUALIA PHARMA INC. | Directeur/Membre du Conseil | 14/07/2011 | 01/08/2014 |
| Directeur Technique/Scientifique/R&D | 14/07/2011 | 29/11/2012 | |
| Corporate Officer/Principal | - | - |
Formation de Shinichi Koizumi
| Tokyo Institute of Technology | Doctorate Degree |
Statistiques
Internationale
| Japon | 5 |
Opérationnelle
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| RAQUALIA PHARMA INC. | Health Technology |
| TSUBOTA LABORATORY INCORPORATED | Commercial Services |
| Entreprise privées | 1 |
|---|---|
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Health Technology |
- Bourse
- Insiders
- Shinichi Koizumi
- Expérience